Arixapharma Inc. logo

Arixa Pharmaceuticals, Inc

Arixa Pharmaceuticals™ is developing oral antibiotics for resistant Gram-negative infections. The lead program is an oral prodrug of Avibactam®, a broad spectrum beta-lactamase inhibitor recently approved by FDA

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.arixapharma.com
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
Address
CA
Palo Alto
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]